Active Biotech

    OverviewSuggest Edit

    Active Biotech is a biotechnology company. It focuses on research and development of pharmaceuticals and vaccines. Active Biotech does research based on knowledge of the autoimmune/inflammatory diseases and cancer. The Company is developing products designed to treat a variety of diseases including multiple sclerosis, lung, renal, and pancreatic cancer.
    TypePublic
    Founded1982
    HQLund, SE
    Websiteactivebiotech.com

    Latest Updates

    Employees (est.) (Feb 2019)14(-12%)

    Key People/Management at Active Biotech

    Michael Shalmi

    Michael Shalmi

    Chairman of the Board
    Helén Tuvesson

    Helén Tuvesson

    President & CEO
    Uli Hacksell

    Uli Hacksell

    Board Member
    Hans Kolam

    Hans Kolam

    CFO
    Helena Eriksson

    Helena Eriksson

    Chief Scientific Officer
    Peter Sjöstrand

    Peter Sjöstrand

    Board Member
    Show more

    Active Biotech Office Locations

    Active Biotech has an office in Lund
    Lund, SE (HQ)
    Scheelevägen 22
    Show all (1)

    Active Biotech Online and Social Media Presence

    Embed Graph

    Active Biotech News and Updates

    Active Biotech AB - Year-end report January - December 2019

                                                                                                                                                    

    Active Biotech announces new direction

    PRESS RELEASE

    Active Biotech Interim report January – September 2019

                                                                                                                               Third quarter in brief

    Active Biotech and NeoTX today announce first patient dosed in the Phase 1b trial of naptumomab estafenatox in combination with durvalumab in solid tumors

    Lund Sweden, October 28 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) and NeoTX announce that the dosing of the first patient in its Phase 1b trial of naptumomab estafenatox (naptumomab, ANYARA) in combination with AstraZeneca’s checkpoint inhibitor IMFINZI® (durvalumab)  for the treatment of advan…

    Product Overview and Scope of Worldwide Castration Resistant Prostate Cancer Treatment Market forecast 2025 | TOP Key Players - Active Biotech, Diagnocure, Glaxosmithkline, Northwest Biotherapeutics, Millennium Pharmaceuticals, Hologic, Spectrum Pharmaceu

    Summary: A new market study, titled “Discover Global Castration Resistant Prostate Cancer Treatment Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday

    Kidney Cancer Drugs Market Demand To Escalate Till 2026 By Global Key Players Pfizer Inc., Novartis International AG, Genentech, Inc., Active Biotech AB, Amgen Inc., Bayer AG, Cipla Limited, Hoffmann-La Roche AG

    Key drug manufacturers in the kidney cancer drugs market are adopting in-organic growth strategies to collaborate with other drug manufacturers and develop renal cell carcinoma drugs Posted via Industry Today. Follow us on Twitter @IndustryToday
    Show more

    Active Biotech Frequently Asked Questions

    • When was Active Biotech founded?

      Active Biotech was founded in 1982.

    • Who are Active Biotech key executives?

      Active Biotech's key executives are Michael Shalmi, Helén Tuvesson and Uli Hacksell.

    • How many employees does Active Biotech have?

      Active Biotech has 14 employees.

    • Who are Active Biotech competitors?

      Competitors of Active Biotech include GT Biopharma, Intercept Pharmaceuticals and Dynavax Technologies.

    • Where is Active Biotech headquarters?

      Active Biotech headquarters is located at Scheelevägen 22, Lund.

    • Where are Active Biotech offices?

      Active Biotech has an office in Lund.

    • How many offices does Active Biotech have?

      Active Biotech has 1 office.